Favipiravir; Fujifilm’s anti-flu drug Favipiravir that treated Ebola is effective for coronavirus(Covid-19)

Coronavirus protective gear

Fujifilm’s anti-flu drug Favipiravir is said to be effective in treating coronavirus Covid-19. Japan Covid-19 patients in Japan has reduced rapidly due to the Favipiravir administration.

China’s Science and Technology Ministry official Zhang Xinmin says Japan-based Fujifilm’s anti-flu drug Favipiravir assisted Covid-19 patients to recover.


Produced by Fujifilm Toyama Chemical, famously known as Avigan, Favipiravir grew support in Japan in 2014.

In 2016, Japan provided Favipiravir as emergency aid for the Ebola virus outbreak in Guinea, noted Reuters.

The drug obtained Chinese approval for manufacturing by Zhejiang Hisun Pharmaceutical to treat adults with new or recurring influenza, according to a filing by the company last month.

Last month, Chinese media reported that the drug received approval as an investigational therapy for Covid-19 coronavirus infection.